Kamar yadda muka sani, a matsayin mafi girma na ciki na jikin mutum, hanta yana kula da muhimman ayyuka na rayuwa kuma yana taka rawa a matsayin "majibincin waliyin jikin mutum".Cututtukan hanta na iya haifar da matsaloli kamar rage garkuwar jiki, rashin lafiya na rayuwa, gajiya mai sauƙi, ciwon hanta, rashin bacci, asarar ci, gudawa, da ƙarin matsaloli masu tsanani kamar “ciwon ƙwayar cuta” da ke lalata gabobin jiki daban-daban.
 
Don samun jiki mai lafiya, ciyar da hanta yana da mahimmanci.Yadda za a ciyar da hanta?Ku zo ku ji ra'ayoyin Farfesa Lin Zhi-Bin, wanda ya dade yana gudanar da bincike kan Ganoderma.
 
Ganoderma ta kariya sakamako a kan hanta
 
Ganoderma lucidum ana ɗaukarsa azaman babban magani don ciyar da hanta tun zamanin da.A cewar "Compendium na Materia Medica", "Ganoderma lucidum yana inganta gani, yana ciyar da hanta qi, kuma yana kwantar da ruhu."

Lin Zhi-Bin, farfesa na Sashen Kimiyyar Magunguna, Makarantar Kimiyyar Kiwon Lafiya ta Jami'ar Peking

 
Farfesa Lin Zhi-Bin ya ce a cikin shirin "Master Talk", "Ganoderma lucidum yana da sakamako mai kyau na kare hanta."

Sakamakon curative na Ganoderma lucidum akan kare hanta

Ko da yake Ganoderma lucidum ba shi da tasirin cutar hanta kai tsaye, yana da immunomodulatory da tasirin hepatoprotective, don haka ana iya amfani da shi azaman magungunan hepatoprotective da immunomodulatory don magani da kula da lafiyar cutar hanta.

A cikin 1970s, kasar Sin ta fara amfani da shirye-shiryen Ganoderma lucidum don magance cutar hanta.Dangane da rahotanni daban-daban, jimillar tasiri mai tasiri shine 73.1% -97.0%, kuma sakamako mai alama (ciki har da adadin maganin asibiti) shine 44.0% -76.5%.Its curative sakamako yana bayyana a matsayin raguwa ko bacewar bayyanar cututtuka kamar gajiya, asarar ci, kumburin ciki da zafi a cikin hanta yankin.A cikin gwaje-gwajen aikin hanta, (ALT) ya koma al'ada ko raguwa.Hanta mai girma da saifa sun koma al'ada ko sun ragu zuwa nau'i daban-daban.Gabaɗaya magana, tasirin Reishi akan m hanta ya fi na kullum hepatitis ko m hepatitis.

A asibiti, ana hada Ganoderma lucidum tare da wasu magunguna da zasu iya cutar da hanta, wanda zai iya gujewa ko rage raunin hanta da kwayoyi ke haifarwa da kuma kare hanta.Sakamakon hepatoprotectiveReishiHar ila yau yana da alaƙa da "tonifying hanta qi" da "ƙarfafa tsokar qi" wanda aka bayyana a cikin tsoffin littattafan likitancin Sin.[Rubutun da ke sama ya fito daga Lin Zhi-Bin's"Lingzhi, Daga Mystery zuwa Kimiyya", Jami'ar Peking Medical Press, P66-67]

Tun farkon shekarun 1970, Farfesa Lin Zhi-Bin ya jagoranci bincike kan illolin harhada magunguna.Ganoderma lucidumkuma sun gano cewa Ganoderma lucidum da samfuran da ke da alaƙa suna da tasirin magunguna da yawa kamar kariyar hanta, rage yawan lipids na jini, rage sukarin jini, tsarin rigakafi, ƙwayar cuta, anti-oxidation, da anti-tsufa.Idan kana son ƙarin sani game da nasarorin ilimi na Farfesa Lin Zhi-Bin a cikin binciken Ganoderma lucidum, da fatan za a kula da "Taron Ilimin Ilimi da Taron Fitar da Sabon Litattafai akan bikin cika shekaru 50 na Binciken Farfesa Lin Zhi-Bin akan Lingzhi"!

Gabatarwar Farfesa Lin Zhi-Bin
 
An haifi Lin Zhi-Bin a Minhou, Fujian.Ya sauke karatu daga sashen kula da lafiya na kwalejin likitanci na birnin Beijing a shekarar 1961 ya zauna a can yana koyarwa.Ya yi nasara a matsayin mataimaki na koyarwa, malami, mataimakin farfesa kuma farfesa a Kwalejin Kiwon Lafiya ta Beijing (wanda aka canza masa suna Jami'ar Kiwon Lafiya ta Beijing a 1985 da Cibiyar Kiwon Lafiya ta Jami'ar Peking a 2002), mataimakin shugaban Makarantar Kimiyyar Kiwon Lafiya ta Jami'ar Peking kuma darektan Cibiyar Nazarin Lafiya ta Jami'ar Peking. Magani na asali, darektan Sashen Kimiyyar Magunguna, kuma Mataimakin Shugaban Jami'ar Kiwon Lafiya ta Beijing.A cikin 1990, Hukumar Digiri ta Ilimi ta Majalisar Jiha ta amince da shi a matsayin mai kula da digiri na uku.
 
Ya yi nasara a matsayin malami mai ziyara a Jami'ar Illinois a Chicago, malami mai girmamawa a Cibiyar Kula da Magunguna ta Perm a Rasha, Farfesa mai ziyara a Jami'ar Hong Kong, Farfesa a Kwalejin Kiwon Lafiya ta Jami'ar Nankai, da Bako. farfesa na Jami'ar Ocean ta kasar Sin, Jami'ar Kiwon Lafiya ta Harbin, Jami'ar Kiwon Lafiya ta Dalian, Jami'ar Kiwon Lafiya ta Shandong, Jami'ar Zhengzhou da Jami'ar Aikin Noma da Gandun daji ta Fujian.
 
Ya yi aiki a matsayin shugaban kwamitin da za a gabatar da zaben kudan zuma na Ke Ofutedere na kungiyar (Apimonddia), memba na kwamitin zartarwa na jam'iyya (IPIMAR) da memba na kungiyar Properate (IPUPHAND) da memba na Pharment na 2014-2018. kuma memba na kwamitin zartarwa na kungiyar likitocin harhada magunguna a kudu maso gabashin Asiya da yammacin Pacific (SEAWP), shugaban kungiyar bincike ta Ganoderma ta kasa da kasa, memba na kwamitin kasa na kungiyar kimiya da fasaha ta kasar Sin, shugaban kungiyar harhada magunguna ta kasar Sin. Al'umma, mataimakin shugaban kungiyar fungi masu cin abinci ta kasar Sin, shugaban girmamawa na kungiyar harhada magunguna ta kasar Sin, mataimakin darektan kwamitin ba da shawarwari kan harkokin harhada magunguna na ma'aikatar lafiya, mamba a kwamitin kwararru na bincike da raya magunguna na kasa, mamba a kwamitin kula da harhada magunguna na kasa. Masanin nazarin magunguna na kasa, memba na rukunin nazarin ma'aikatar harhada magunguna ta gidauniyar kimiyyar dabi'a ta kasar Sin, memba na Cibiyar Binciken Fasahar Fasahar Injiniya ta Kasa Edible Fungi, memba na kwamitin fasaha na kwararru na Cibiyar Nazarin Injiniya ta kasa ta Fasaha ta JUNCAO, da dai sauransu. .
 
Ya ci gaba da zama babban editan "Jarida na Jami'ar Kiwon Lafiya ta Beijing", mataimakin editan "Acta Pharmacologica Sinica" da "Jarida ta Sinawa na Clinical Pharmacology and Therapeutics", mataimakin editan "Bulletin Pharmacological na kasar Sin" da "Masanin harhada magunguna na kasar Sin". ", memba na edita na "Acta Pharmaceutica Sinica", "Jarida Pharmaceutical na kasar Sin", "Jaridar Sinanci na Integrated Traditional and Western Medicine", "Jarida na Sinanci na Pharmacology da Toxicology", "Magungunan Sinanci", "Acta Edulis Fungi", " Ci gaba a Kimiyyar Jiki", "Bincike Pharmacological" (Italiya), da kuma memba na kwamitin edita na "Biomolecules & Therapeutics" (Korea) da "Acta Pharmacologica Sinica".
 
Ya dade yana aiki a cikin bincike game da tasirin magunguna da tsarin magungunan ƙwayoyin cuta, magungunan immunomodulatory, magungunan endocrin da magungunan ƙwayoyin cuta, kuma ya shiga cikin haɓaka sababbin magunguna da kayan kiwon lafiya.Shahararren masanin binciken ganoderma ne a gida da waje.
 
Ya lashe lambar yabo ta biyu (1993) da lambar yabo ta uku (1995) na lambar yabo ta Hukumar Ilimi ta Jihar Kimiyya da Fasaha (Class A), lambar yabo ta biyu na lambar yabo ta Kimiyya da Fasaha ta Kasa da Ma'aikatar Ilimi ta zaba (2003). da lambar yabo ta biyu na lambar yabo ta ci gaban kimiyya da fasaha ta Beijing (1991) da lambar yabo ta uku (2008), lambar yabo ta farko na kayan koyarwa na ma'aikatar lafiya ta kasa (1995), lambar yabo ta biyu na lambar yabo ta Kimiyya da Fasaha ta Fujian (2016) ), lambar yabo ta uku ta lambar yabo ta kimiyya da fasaha ta Guanghua (1995), lambar yabo ta ci gaban al'adu da ilimi na microbiology (Taipei) lambar yabo ta 2006, lambar yabo ta uku ta ci gaban kimiyya da fasaha na ƙungiyar Sinawa ta haɗin gwiwar magungunan gargajiya da na yammacin Turai. (2007), da sauransu.
 
A cikin 1992, Majalisar Jiha ta amince da shi don ya more alawus na musamman na gwamnati ga ƙwararrun masu ba da gudummawa.A cikin 1994, an ba shi lambar yabo a matsayin ƙwararren matashi da matsakaicin shekaru tare da gudummawar da ma'aikatar lafiya ta bayar.

Haɓaka Al'adun Kiwon Lafiyar Millennia
Taimakawa Wajen Lafiya Ga Kowa